In pancreatic cancers, CAFs expressing IRAK4 can induce resistance to chemotherapy by IL1β secretion that activate the NFκB pathway in pancreatic cancer cells [167]. This evidence concerns the gene IRAK4 and familial pancreatic carcinoma.